864
On 31 August 2006, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number 393. The active ingredient is autologous CD34+ cells transfected with retroviral vector containing the human gp91 (phox) gene for treatment of chronic granulomatous disease.